Page 19 - Sun Pharma
Sun Pharma gains after falling 6% on Wednesday
The company said none of the nine observations were characterized by the USFDA as repeat observations
 "Sun Pharma gains after falling 6% on Wednesday")
US FDA raises fresh concerns on Sun Pharma's Halol plant
The Halol plant is a key manufacturing unit for Sun Pharma, which earns about half its revenue from the US market
 "US FDA raises fresh concerns on Sun Pharma's Halol plant")
Sun Pharma says US FDA finds more concerns at Halol plant
It is unclear what violations the FDA found; Sun did not disclose them
 "Sun Pharma says US FDA finds more concerns at Halol plant")
Sun Pharma dips 5% on confirmation of USFDA inspection of Halol facility
The stock was down 5% after the company confirms that Halol facility has undergone an inspection by USFDA
Sun Pharma tanks 4% on reports USFDA issued notice on Halol plant
The stock has shed 7% in the last 4 days, including today
 "Sun Pharma tanks 4% on reports USFDA issued notice on Halol plant")
Regulatory issues keep Sun Pharma stock under cloud
Stock is 40% below its all-time high touched last year
 "Regulatory issues keep Sun Pharma stock under cloud")
Sun Pharma's sharpens emerging market focus with $60 mn acquisition in Russia
Sun Pharma will pay $24 mn for 85% equity and will assume $36 mn debt as part of the transaction
 "Sun Pharma's sharpens emerging market focus with $60 mn acquisition in Russia")
Sun Pharma acquires Russian company for $60 million
Sun Pharma gained ownership of 85% of Biosintez's equity stake for $26 mn; it also owned a company debt of $36 mn
Sun Pharma ties up with Madhya Pradesh government to combat malaria
The funds for the same will come from the Corporate Social Responsibility funds earmarked by the company
Sun Pharma gains on strong Q2 results
The stock rallied 6% to Rs 708 on BSE in early morning trade.
Sun Pharma profit doubles on sales growth, licensing income
Net profit rises to Rs 2,235 crore in Q2 FY 17 as against Rs 1,028 crore in same period last year
 "Sun Pharma profit doubles on sales growth, licensing income")
Sun Pharma Q2 net up over two-fold at Rs 2,235 cr
Sales in its largest market, the United States, rose 9%, while those in India rose 11% in emerging markets
 "Sun Pharma Q2 net up over two-fold at Rs 2,235 cr")
Cartelisation probe against Dr Reddy's, Sun Pharma in US
Pharma stocks tumble 4% on BSE; Sun Pharma down 7.4%, Dr Reddy's loses 5.6%
 "Cartelisation probe against Dr Reddy's, Sun Pharma in US")
Multiple pain points for Sun Pharmaceutical
Pricing pressures in US market now aggravated by fallout of drug price rise probe
 "Multiple pain points for Sun Pharmaceutical")
Investors in pharma shares lose Rs 30,200 crore in single day
Sun Pharma, Dr Reddy's, Jubilant Life, Strides Shasun, Aurobindo Pharma were down 5% each over possible US probe into cartelisation
 "Investors in pharma shares lose Rs 30,200 crore in single day")
Pharma stocks under pressure on US anti-trust probe
Suspense over US election result also weighs on market as stocks fall 3-7 percent
 "Pharma stocks under pressure on US anti-trust probe")
Sun Pharma launches blood pressure drugs in US
Sun Pharmaceutical Industries on Thursday said it has launched generic versions of Daiichi Sankyo medicines
Sun Pharma buys eye care specialist Ocular Tech for $40m
Sun will also pay more contingent on meeting drug development and sales milestones as well as tiered royalty on sales of Seciera for the company
 "Sun Pharma buys eye care specialist Ocular Tech for $40m")
Sun Pharma completes Rs 675-crore share buyback
The comapny's stock was trading at Rs 742, down 0.66 per cent from its previous close, on BSE
Sun enters vaccine space with dengue shot
This is the second tie-up between the International Centre for Genetic Engineering and Biotechnology and Sun Pharmaceuticals
